This fact sheet provides an overview of PATH’s project to introduce fortified rice in Myanmar. The goal of the project is to reduce micronutrient deficiencies in the population while also creating income-generating opportunities. PATH is working with government and private-sector partners to create a thriving private market for fortified rice and to distribute it to vulnerable populations.

PATH collaborates with the US Department of Defense (DoD) to advance global health innovations. This fact sheet provides examples of successes that PATH, DoD, and our partners have had in working to adapt, test, and expand access to tools and technologies that can reduce illness in the world’s most vulnerable populations.

As part of PATH’s work in vaccine and pharmaceutical delivery technologies, this poster highlights PATH’s four-phase approach to designing a dissolvable microarray patch (MAP) for vaginal delivery of rilpivirine. In addition, the poster discusses the ways by which the approach has helped to define design requirements for an effective and discreet method (i.e., applicator) for delivering the long-lasting rilpivirine MAP for HIV pre-exposure prophylaxis.

Hazard analysis critical control points (HACCP) planning is a critical step in ensuring the safety and quality of any food product, including donated and processed human milk. PATH developed this trainer’s guide and staff workbook to guide HACCP workshops in human milk banks.

This guide provides an overview of water-filter products within PATH's Springboard Initiative ecosystem that feature the PATH-developed C1 Common Interface—a common-connection point and platform solution to promote product interchangeability, standardization, and market efficiency. Cartridges from one manufacturer can be used in water filters from another. This guide is primarily intended for professionals who seek balanced, introductory-level information on available water-filter products appropriate for low- and/or lower-middle income consumers in developing countries. It is not comprehensive and covers only products with the C1 Common Interface. The information presented is appropriate for commercial, public-sector, or nonprofit organizations interested in wholesale quantities.

Vaccines are one of the most powerful, lifesaving, and cost-eff­ective health tools. Yet today one in five children around the world are not fully immunized with even the most basic vaccines. By 2020, we can bring the full power of immunization to all people. This infographic outlines the vital role the US government plays in making this vision a reality.

This fact sheet describes a new ecosystem of interchangeable water-filter products from a range of companies based on the PATH-developed C1 Common Interface—a simple, common-connection point and platform solution designed to work with different filters and different devices.

PATH’s Center for Malaria Control and Elimination is building on our unparalleled portfolio of malaria tools and projects, encompassing a broad collection of competencies and expertise, to advance efforts toward elimination, and ultimately eradication, of both P. falciparum and P. vivax malaria.

This tool is a national-level quantification tool for basic neonatal resuscitation commodities, although it can be helpful for the district and facility level. It is designed only to provide estimates of product quantities for planning and cost simulations and is not intended for planning detailed distribution. The format of the tool includes simple design elements, such as graphics and navigation arrows, to guide users through the tool.

The United States has a long history of leadership in global immunization. This educational fact sheet created by PATH and several advocacy partners highlights US government efforts in global immunization, including support for Gavi, the Vaccine Alliance; UNICEF; and the World Health Organization, as well as immunization activities carried out by the US Agency for International Development, US Department of Defense, and various agencies within the Department of Health and Human Services.

The regulation of health technologies is a critical component of every country’s public health system and ensures that high-quality, safe health technologies reach the people who need them most. To harness momentum for regulatory harmonization, the Pan-African Parliament, New Partnership for African Development, and African Union Commission spearheaded the development of the African Union Model Law on Medical Products Regulation, which guides member states and regional economic communities in harmonizing regulatory systems and providing an enabling environment for the development and scale-up of health technologies.

The BID Initiative is grounded in the belief that better data plus better decisions will lead to better health outcomes. The infographic depicts the initiative’s approach through Products, Policies & Practices, People, and Packaging.

This document includes a narrative and supporting graphic illustrating our theory on how to improve data systems and accelerate data use over a ten-year period in order to perpetuate a cycle of better data production and enhanced use of information to improve the performance of health systems.

This two-page issue brief provides important background on why policymakers and global health leaders must invest in health supply chains to help close the immunization gap, as well as provides resources on action steps on how to do so.

This capability statement highlights PATH’s efforts to strengthen supply chains in India. Our work has centered on the development, introduction, and scale-up of technology and system innovations that increase the efficiency and effectiveness of India’s public health programs.

This capability statement highlights PATH’s supply chain strengthening work in Senegal. Collaborating with partners since 2001, we work on a variety of projects to improve the efficiency and effectiveness of the country’s medical supply systems.

This capability statement highlights the work PATH and its partners in Uganda have done since 2002 to improve and support vaccine introductions as well as strengthen the immunization supply chain at all levels.